T

Tandem Diabetes Care
D

TNDM

16.785
USD
-0.28
(-1.61%)
مغلق
حجم التداول
36,181
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
1,118,001,953
أصول ذات صلة
ABT
ABT
0.210
(0.16%)
134.280 USD
BSX
BSX
0.625
(0.60%)
104.250 USD
DXCM
DXCM
-0.640
(-0.77%)
82.920 USD
EW
EW
-0.480
(-0.62%)
76.540 USD
ISRG
ISRG
3.16
(0.58%)
543.88 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
PODD
PODD
-0.21
(-0.07%)
301.15 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
TMO
TMO
1.69
(0.40%)
429.33 USD
ZBH
ZBH
0.090
(0.10%)
93.600 USD
المزيد
الأخبار المقالات

العنوان: Tandem Diabetes Care

القطاع: Healthcare
الصناعة: Medical Devices
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.